ORAGENICS, INC. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
ORAGENICS, INC. (OGEN) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $2.06 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-29.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2019-03-29
- ORAGENICS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2017 was $2.06K.
- ORAGENICS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2013 was -$2.63M.
- ORAGENICS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2012 was -$668.38K, a 648.34% decline from fiscal 2011.
- ORAGENICS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2011 was $121.89K.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month as first filed |
|---|---|---|
| 2017-12-31 | $2.06K 10-K · filed 2019-03-29 | |
| 2013-12-31 | -$2.63M 10-K · filed 2014-02-28 | |
| 2012-12-31 | -$668.38K 10-K · filed 2014-02-28 | $158.43K 10-K · filed 2013-03-26 |
| 2011-12-31 | $121.89K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |